[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352880-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352880-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-ubiquitin-signaling-vulnerabilities-in-keap1-inactivated-lung-cancer","Targeting ubiquitin signaling vulnerabilities in KEAP1-inactivated lung cancer","","Lung cancer cells depend on protein homeostasis regulators, especially the ubiquitin-proteasome system (UPS), to sustain malignancy. UPS gene alterations, including E3 ubiquitin ligases and deubiquitinating enzymes, can create context-specific therapeutic vulnerabilities. CRISPR screens in metabolically stressed murine lung cancer models reveal that KEAP1 deletion activates Nrf2 and increases Aldh3a1, driving reductive stress and suppressing tumor growth, and uncovering druggable co-vulnerabilities.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-ubiquitin-signaling-vulnerabilities-in-keap1-inactivated-lung-cancer/352880/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-ubiquitin-signaling-vulnerabilities-in-keap1-inactivated-lung-cancer/352880.png","ImageObject",300,407,{"name":42,"@type":43},"Aditya","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does KEAP1 loss affect tumor cell signaling in this study?","Question",{"text":63,"@type":64},"Keap1 deletion activates Nrf2 and upregulates Aldh3a1, leading to elevated reductive stress and suppressed tumor growth in the studied models.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What experimental approach was used to identify vulnerabilities?",{"text":68,"@type":64},"CRISPR screens were performed in metabolically stressed murine lung cancer models, followed by combinatorial CRISPR dropout screens to test co-dependencies.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are E3 ubiquitin ligases and DUBs important here?",{"text":72,"@type":64},"Genetic alterations in UPS components are common and can generate context-dependent therapeutic dependencies; in KEAP1-inactivated tumors, druggable E3s and DUBs emerge as Keap1-dependent co-vulnerabilities.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352880,1790154884,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Article  \nTargeting ubiquitin signaling vulnerabilities in KEAP1-inactivated lung cancer  \nVarun Jayeshkumar Shah1,12, Oliver Hartmann  2,3,4,12, Martin Wegner 1, Cristian Prieto-Garcia 1,5,6,  \nRubina Kazi1, Viktoria von Heyl zu Herrnsheim2,3,4, Amin Wanli7,8, Igor Mačinković7,8, Bianka Bohnacker 2,3,4, Koraljka Husnjak 1, Dmitry Namgaladze8, Mathias Rosenfeldt9, Manuel Kaulich 1,10, Markus E Diefenbacher 2,3,4 ✉ & Ivan Dikic 1,11 ✉  \nAbstract  \nLung cancer cells rely on protein homeostasis regulators, particularly the ubiquitin-proteasome system (UPS), to sustain malignancy. Genetic alterations in UPS components, such as E3 ubiquitin ligases (E3s) and deubiquitinating enzymes (DUBs), are common and create context-dependent therapeutic dependencies. To investigate how these genetic alterations drive tumor formation, we conducted CRISPR screens on metabolically stressed murine lung cancer models and identiﬁed speciﬁc cancer dependencies, including ubiquitin ligase subunit KEAP1 . Although KEAP1 is frequently mutated in aggressive non-small cell lung cancers (NSCLC,~15%), our ﬁndings reveal an unexpected proto-oncogenic role for KEAP1 in a genetically deﬁned subset of NSCLC. Mechanistically, Keap1 deletion activated Nrf2 and upregulated Aldh3a1 . This led to elevated reductive stress and suppressed tumor growth. Given the poor prognosis of KEAP1-mutated patients, combinatorial CRISPR dropout screens revealed druggable E3s and DUBs as Keap1-dependent co-vulnerabilities. Notably, depleting these co-dependencies, such as the E3 ligases Herc2, Ubr4 and Huwe1 ablated the in vivo development of Keap1-inactivated tumors. We demonstrate that targeting the UPS represents an underexplored, promising therapeutic approach for patients with KEAP1-inactivated tumors, especially under metabolic stress.  \nKeywords NSCLC; CRISPR/Cas9; Keap1; Reductive Stress; UbiquitinProteasome System  \nSubject Categories Cancer; Post-translational Modiﬁcations & Proteolysis [https://doi.org/10.1038/s44318-026-00737-9](https://doi.org/10.1038/s44318-026-00737-9)  \nReceived 22 November 2024; Revised 3 February 2026; Accepted 11 February 2026  \nPublished online: 20 March 2026  \nIntroduction  \nDuring oncogenic transformation, cells experience elevated levels of proteotoxic stress as a consequence of rapid growth, metabolic stress and genomic imbalances. These alterations impose a strong selective pressure and are a prerequisite to establishing the‘hallmarks of cancer’ (Deshaies, 2014; Hanahan, 2022) . Furthermore, genetic alterations in proto-oncogenes and tumor suppressors not only drive selective pressure but also directly affect tumor growth and, ultimately, patient performance and survival expectancy during therapy. As clinically relevant examples, patients harboring alterations in the MAPK signaling pathway, such as activating mutations in the oncogenes KRAS along with alterationsin tumor suppressor genes TP53 (p53), liver kinase B1/serine/ threonine-protein kinase STK11 (LKB1/STK11) and Phosphatase and tensin homolog (PTEN), develop more aggressive non-small cell lung carcinoma (NSCLC) tumors, with a high frequency of metastasis, and limited treatment options (Cancer Genome Atlas Research Network, 2012; Collisson et al, 2014) .  \nRecent advances towards molecularly targeted therapies, such asthe KRAS inhibitors (KRASi) Sotorasib and Adagrasib, show signiﬁcant improvements in the treatment of KRAS-mutated NSCLC patients (Lanman et al, 2020; Fell et al, 2020), yet their efﬁcacy is limited by inevitable resistance, exacerbating poor outcomes and high mortality rates. Furthermore, recent research suggests that KRAS-driven cancers are addicted to proteostasis for growth (Awad et al, 2021; Lv et al, 2023), and complementary therapies that enhance proteostatic stress may be feasible.  \nIn the past, the appreciation that UPS is a contributor to cancer development and disease progression led to the development of targeted therapies, such as the proteasome inhibitors","cbCaidXZTwQNM5Rp","https://ap.wps.com/l/cbCaidXZTwQNM5Rp","pdf",7255783,"English","# Introduction\n## Proteotoxic stress and proteostasis in cancer\n## UPS-targeted therapies and limitations\n# Abstract\n## KEAP1-dependent vulnerabilities and mechanisms","[{\"question\":\"How does KEAP1 loss affect tumor cell signaling in this study?\",\"answer\":\"Keap1 deletion activates Nrf2 and upregulates Aldh3a1, leading to elevated reductive stress and suppressed tumor growth in the studied models.\"},{\"question\":\"What experimental approach was used to identify vulnerabilities?\",\"answer\":\"CRISPR screens were performed in metabolically stressed murine lung cancer models, followed by combinatorial CRISPR dropout screens to test co-dependencies.\"},{\"question\":\"Why are E3 ubiquitin ligases and DUBs important here?\",\"answer\":\"Genetic alterations in UPS components are common and can generate context-dependent therapeutic dependencies; in KEAP1-inactivated tumors, druggable E3s and DUBs emerge as Keap1-dependent co-vulnerabilities.\"}]","Targeting ubiquitin signaling vulnerabilities in KEAP1-inactivated lung cancer | PDF",1790101839,76,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73406bda1998f960e13df2b5ead965ad.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2f7e588a542a7dc53777871df3b8894.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcbba6573ded9649c5b8d4f019f59916.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6037a9de4443e6154ab180fad1d6c8f4.webp",980,1301]